SUPERIOR

PERFORMANCE BY DESIGN

ROBUST

IN THE FACE OF CHANGE

Optimise Your Pharmaceutical Workflow with

METTLER TOLEDO’s spectrophotometers and analysers

Learn More

UV5 Bio Spectrophotometer

UV5 Spectrophotometer

UV5 Nano Spectrophotometer

UV5 Nano 

Spectrophotometer

UV7 Spectrophotometer

Superior Performance By Design

Receive trustworthy results every time with our UV Vis instruments. Find the right one to meet your specific requirements. The instrument is always ready to use, as no time is required for warm up. FastTrackTM UV/Vis technology provides results in seconds.

Click here to find out more 

Notepad-sizedFootprint

The instrument can be operated as standalone and doesnotrequirePCconnection, saving bench-top space or can be enhanced with connection to LabXTM software.

Click here to find out more 

CompliantwiththeLatestPharmacopeias

METTER TOLEDO’s UV7 spectrophotometers is tested according to the latest changes in USP and Ph.Eur. to guarantee full compliance in regulated environments. Regulatory Compliance:

  • ALCOA+ principals for Data Integrity
  • UV7 with LabX Software supports 21CFR11 Compliance
  • Certiref and Linset available for fast, automated
  • verification of USP/EP performance

Enhanced Workflows:

  • Guided workflows for improved data quality
  • Automated Calculations - Avoid transcription/calculation errors

On-lineMicrobialAnalyzerReal-timeMonitoringandControl

For pharmaceutical manufacturers, on-line measurement provides process control and real-time monitoring of their water quality.

Click here to find out more 

Find out more 

➤ www.mt.com/uvvis

➤ www.mt.com/7000rms

Discover more ▼

Go to article: Home | Covid-19 and the anti-vax movementGo to article: In this issueGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Mettler Toledo Company InsightGo to article: Mettler ToledoGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: WipotecGo to article: PuroliteGo to article: VEGA AustraliaGo to article: Gerteis Company Insight Go to article: GerteisGo to article: CommentGo to article: US election: Trump and Biden's priorities in the Covid-19 responseGo to article: Covid-19 disruption to trials declines, but recruitment is slowGo to article: Covid-19 vaccine developments across the globeGo to article: Eli Lilly and Regeneron’s EUA bids trigger concerns over available Covid-19 dataGo to article: AstraZeneca’s quick Covid-19 vaccine trial restart splits opinionGo to article: Q&A: Atomwise’s journey from discoverer to developerGo to article: Pfeiffer VacuumGo to article: Koehler eClinicalGo to article: Phoenix Company Insight Go to article: PhoenixGo to article: In DepthGo to article: How to combat vaccine hesitancy in the age of Covid-19Go to article: How Covid-19 has put clinical research’s diversity problem in the spotlight Go to article: No need for animal testing: improving vaccine research with GenoskinGo to article: Gout: drug development for an age-old diseaseGo to article: Treating chronic primary pain in the UKGo to article: Breast cancer breakthrough: could a new therapy silence stubborn TNBC?Go to article: Is quantum computing pharma's next big disruptor?Go to article: MimotopesGo to article: OptelGo to article: Solvias Company Insight Go to article: SolviasGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: IWA Consulting Company Insight Go to article: IWA consultingGo to article: Nipro pharmapackagingGo to article: SwiftpakGo to article: EventsGo to article: Next issue